COVID-19 vaccination in Germany

Last updated
COVID-19 vaccination in Germany
Germany map of fully vaccinated people by percentage of population by state as of 23rd of June 2021.png
Map of Germany by state. Percentage of people getting fully vaccinated by population as of June 23, 2021. [1]
Date27 December 2020 (2020-12-27) – present
LocationNationwide
Cause COVID-19 pandemic
TargetFull immunisation of people in Germany against COVID-19
Participants55,869,314 people with one dose
52,503,166 people fully vaccinated (19 September 2021)
Website Official Website

The COVID-19 vaccination campaign in Germany began on 26 December 2020. [2] As of 19 September 2021, 55,869,314 people have received at least one dose (67.2 % of total population), while 52,503,166 people have been fully vaccinated (63.1 % of total population). [3]

Contents

Vaccines on order

German vaccination certificate with evidence of two-dose of COVID-19 vaccination Impfpass mit COVID 19 Impfungen.jpg
German vaccination certificate with evidence of two-dose of COVID-19 vaccination

There are several COVID-19 vaccines at various stages of development around the world. The ones listed as "pending" in the table below are under review by the European Medicines Agency as of 15 May 2021. [4]

VaccineApprovalDeployment
Pfizer–BioNTech Green check.svg 21 December 2020Green check.svg 27 December 2020
Moderna Green check.svg 6 January 2021Green check.svg 12 January 2021
Oxford-AstraZeneca Green check.svg 29 January 2021Green check.svg 7 February 2021
Janssen Green check.svg 11 March 2021Green check.svg 5 May 2021
CoronaVac PendingPending
Novavax PendingPending
CureVac PendingPending
Sputnik V PendingPending

The German Immunization Committee (STIKO) initially recommended jabs from AstraZeneca [5] and Janssen only for patients ages 60 and above after reports of blood clot post-vaccination, but this was made available to everyone by the federal government on May 6, 2021 [6] and May 10, 2021, [7] respectively.

Doses delivered

As of 19 July 2021

Timeline of vaccination

COVID-19 vaccination center in Hall 4 of Cologne Trade Fair. COVID-19 vaccination center, fair grounds Cologne-6467.jpg
COVID-19 vaccination center in Hall 4 of Cologne Trade Fair.

Priority groups

At the beginning of the vaccination campaign, the vaccine was planned to be distributed in four priority groups. [8]

Vaccination group 1

The first priority group received their first vaccination on 26 December 2020. Everyone ages 80 and above, residents & caretakers of senior residents and high risk medical personnel are included in this group.

Vaccination group 2

This group consists of everyone ages 70 to 79, people with high risk preexisting conditions or down syndrome or psychologically impaired and their caretakers, caretakers of pregnant women, and other medical personnel not included in group 1.

Vaccination group 3

Group 3 consists of everyone ages 60 to 69, people with moderate preexisting conditions and their caretakers, employees of the government, shops, and vital infrastructure, and teachers.

Vaccination group 4

Everyone under the age of 60, but at least 16 years old, who are not included in the above vaccination group will be the last to get inoculation once most members of the top three priority groups receive their first dose. At a press conference on 26 April 2021, chancellor Angela Merkel promised to remove the prioritization by June, [9] with Health Minister Jens Spahn later announcing its end on June 7, 2021. [10] However, the states of Baden-Württemberg, Bavaria, and Berlin decided to enable this group to also get vaccinated through a doctor's office starting on 17 May 2021. [11] [12] [13]

On 27 May 2021, chancellor Angela Merkel announced the extension of this priority to include children ages 12 to 15, on the condition that at least one existing vaccine is approved for use in this age range by the European Medicines Agency (EMA). [14]

Slowing of vaccination campaign and government response

On 8 August 2021, it was reported that in response to a decreasing demand for vaccinations, in particular the Oxford–AstraZeneca COVID-19 vaccine, the Health Ministry would, starting from 16 August, distribute vaccines to the 16 states on the basis of reported demand, instead of the maximum feasible amounts. For the same reason, states projected in a survey by Die Welt that they would return over 2 million vaccine doses to the federal government. Development minister Gerd Müller told the newspaper that the amount of 30 million vaccine doses already promised should be increased in view of the situation, and that as the next step, the capacities for domestic production in poorer countries should be improved. [15]

From 13 to 19 September, mobile vaccination centers were set up on public transport, mosques and football fields as part of a campaign to increase the vaccination rate in the population. [16]

Statistics

Vaccination figures were obtained from the RKI, updated every business day and correspond to progress on the previous day. [17] Starting from April, inoculations can also be administered at a doctor's office alongside the existing vaccination center and mobile teams [18] and from 7 June at a company's physician office. A first dose is described as a person who received at least one COVID-19 vaccine doses, while a full dose stands for a person who completed the vaccination process with the prescribed doses.

Cumulative vaccinations

Vaccinations per day

Vaccination by federal state

First and second vaccination by federal state
Federal stateVaccinated populationPercentage of population vaccinated
first dosefull dosefirst dosefull dose
Flag of Baden-Wurttemberg.svg Baden-Württemberg 6,435,3494,997,37057.97%45.02%
Flag of Bavaria (lozengy).svg Bavaria 7,540,5755,701,13657.45%43.44%
Flag of Berlin.svg Berlin 2,147,0581,638,43758.51%44.65%
Flag of Brandenburg.svg Brandenburg 1,375,1871,054,57854.53%41.82%
Flag of Bremen.svg Bremen 466,271335,93968.45%49.32%
Flag of Hamburg.svg Hamburg 1,108,873802,95758.39%42.28%
Flag of Hesse.svg Hesse 3,685,0352,802,30758.60%44.57%
Flag of Mecklenburg-Western Pomerania.svg Mecklenburg-Vorpommern 936,360749,99958.23%46.64%
Flag of Lower Saxony.svg Lower Saxony 4,951,1803,477,26361.94%43.50%
Flag of North Rhine-Westphalia.svg North Rhine-Westphalia 11,261,3158,676,89862.75%48.35%
Flag of Rhineland-Palatinate.svg Rhineland-Palatinate 2,483,5231,716,64460.66%45.33%
Flag of Saarland.svg Saarland 637,961489,31864.64%49.58%
Flag of Saxony.svg Saxony 2,059,1091,716,64450.57%42.16%
Flag of Saxony-Anhalt.svg Saxony-Anhalt 1,217,594963,73055.48%43.91%
Flag of Schleswig-Holstein.svg Schleswig-Holstein 1,828,3901,375,48962.97%47.37%
Flag of Thuringia.svg Thuringia 1,153,817935,18654.08%43.84%
Bundeswehr Kreuz Black.svg Bundespolizei-Logos.svg Bundeswehr / German Federal Police 180,891140,916
Flag of Germany.svg Germany 49,468,48837,713,91559.48%45.35%
Total injected doses87,182,403
As of 16 July 2021 per data from Robert Koch Institut.

Incidents

In August 2021, authorities in north Germany found that a nurse injected saline instead of vaccine, and had to ask more than 8,000 people to get repeat Covid vaccinations. [19]

Related Research Articles

The Joint Committee on Vaccination and Immunisation (JCVI) is an independent expert advisory committee that advises United Kingdom health departments on immunisation, making recommendations concerning vaccination schedules and vaccine safety. It has a statutory role in England and Wales, and health departments in Scotland and Northern Ireland may choose to accept its advice.

Serum Institute of India (SII) is an Indian biotechnology and biopharmaceuticals company. It is the world's largest manufacturer of vaccines located in the city of Pune, India and was founded by Cyrus Poonawalla in 1966. The company is a subsidiary of the holding company 'Cyrus Poonawalla Group'.

COVID-19 pandemic in Germany Ongoing COVID-19 viral pandemic in Germany

The COVID-19 pandemic in Germany is part of the ongoing worldwide pandemic of coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2. On 27 January 2020, the first case in Germany was confirmed near Munich, Bavaria. By mid February, the arising cluster of cases had been fully contained. On 25 and 26 February, multiple cases related to the Italian outbreak were detected in Baden-Württemberg. A carnival event on 15 February in Heinsberg, North Rhine-Westphalia, was attended by a man identified as positive on 25 February; in the outbreak which subsequently developed from infected participants, authorities were mostly no longer able to trace the likely chains of infections. On 9 March, the first two deaths in Germany were reported from Essen and Heinsberg. New clusters were introduced in other regions via Heinsberg as well as via people arriving from China, Iran and Italy, from where non-Germans could arrive by plane until 17–18 March. From 13 March, German states mandated school and kindergarten closures, postponed academic semesters and prohibited visits to nursing homes to protect the elderly. Two days later, borders to Austria, Denmark, France, Luxembourg and Switzerland were closed. By 22 March, curfews were imposed in six German states while other states prohibited physical contact with more than one person from outside one's household.

Oxford–AstraZeneca COVID-19 vaccine Viral vector vaccine for prevention of COVID-19 by Oxford University and AstraZeneca

The Oxford–AstraZeneca COVID-19 vaccine, codenamed AZD1222, and sold under the brand names Covishield and Vaxzevria among others, is a viral vector vaccine for prevention of COVID-19. Developed in the United Kingdom by the Oxford University and British-Swedish company AstraZeneca, using as a vector the modified chimpanzee adenovirus ChAdOx1. The vaccine is given by intramuscular injection. Studies carried out in 2020 showed that the efficacy of the vaccine is 76.0% at preventing symptomatic COVID-19 beginning at 22 days following the first dose and 81.3% after the second dose. A study in Scotland found that, for symptomatic COVID-19 infection after the second dose, the vaccine is 81% effective against the Alpha variant, and 61% against the Delta variant.

COVID-19 vaccination in the United Kingdom Immunisation against COVID-19

The COVID-19 vaccination programme in the United Kingdom is an ongoing mass immunisation campaign for coronavirus disease 2019 (COVID-19) during the COVID-19 pandemic in the United Kingdom. The UK's vaccination rollout was the world's first mass immunisation programme for the disease when it began on 8 December 2020 after Margaret Keenan received her first dose of two. As of 6 October 2021, 49,068,705 first doses and 45,078,529 second doses of a vaccine had been administered across the UK.

The COVID-19 vaccination program in the Philippines is an ongoing mass immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in Australia Ongoing COVID-19 vaccine program in Australia

The general COVID-19 vaccination in Australia program began on 22 February 2021 in response to the COVID-19 pandemic, and will continue with the goal of vaccinating all willing Australians before 2022. Front-line workers and aged care staff and residents will be the first Australians to be inoculated, before a gradual phased release to less-vulnerable and lower-risk population groups throughout 2021. The Therapeutic Goods Administration (TGA) approved four vaccines for Australian use in 2021: the Pfizer–BioNTech vaccine on 25 January, the Oxford–AstraZeneca vaccine on 16 February, Janssen vaccine on 25 June and the Moderna vaccine on 9 August. Although approved for use, the Janssen vaccine is not included in the Australian vaccination program.

European Commission–AstraZeneca COVID-19 vaccine dispute Dispute between the European Union and AstraZeneca

A dispute broke out in January 2021 between the European Commission and the pharmaceutical company AstraZeneca AB about the provision of COVID-19 vaccines during the COVID-19 pandemic, and, in February, spilled out into a dispute over Article 16 of the Northern Ireland Protocol. Vaccination proceeded apace in the UK but more slowly in the EU, and by the end of March 2021, over 30% of the UK population had received at least one dose of vaccine compared to about 8% of the EU population. This was partly due to limited availability of the AstraZeneca vaccine in the EU. The World Health Organization and the European Medicines Agency continued to state that the vaccine was safe and effective. However, a representative of the European Medicines Agency said in June that vaccines based on the mRNA technology should be preferred if available for all age groups, including for the over 60s.

COVID-19 vaccination in Romania started on 27 December 2020. It was announced that the process would be divided into three phases. Medical personnel would be vaccinated first, followed by the population at risk, and finally by the rest of the population. Vaccination was declared free and non-mandatory. As of May 2021, four types of vaccines were authorized to be used in Romania. This is the largest vaccination campaign in the modern history of Romania.

COVID-19 vaccination in the Republic of Ireland Immunisation plan against COVID-19

The COVID-19 vaccination programme in the Republic of Ireland is an ongoing mass immunisation campaign that began on 29 December 2020 in response to the COVID-19 pandemic in the Republic of Ireland. Ireland's vaccination rollout has been praised as one of the most successful rollouts in the world and is currently ranked number one in the European Union in terms of its percentage of adult population fully vaccinated.

COVID-19 vaccination in Canada COVID-19 vaccination programme in Canada

The COVID-19 vaccination program in Canada is an ongoing, intergovernmental effort coordinated between the bodies responsible in the Government of Canada to acquire and distribute vaccines to individual provincial and territorial governments who in turn administer authorized COVID-19 vaccines during the COVID-19 pandemic in Canada. Some provinces have asked local municipal governments, hospital systems, family doctors and independently owned pharmacies to aid in part, or in full with vaccination rollout. The vaccination effort in full is the largest such immunization effort in the nation's history; it started in mid-December 2020 and is currently ongoing.

On 29 January 2021, Algeria launched a coronavirus vaccination campaign, a day after receiving its first shipment of 50,000 doses of the Russia's Sputnik V vaccine. As of 6 June 2021, around 2.5 million doses have been administered. Algeria is currently vaccinating its population with both Sputnik V and Oxford-AstraZeneca vaccines.

The COVID-19 vaccination in Morocco is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in Botswana is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in Africa Immunisation programme against COVID-19 in Africa

COVID-19 vaccination programs have begun in many countries and territories in Africa. As of 5 July 2021, vaccination campaigns had started in 51 African countries with 36.5 million people receiving at least one dose.

COVID-19 vaccination in Vietnam Plan to immunize against COVID-19 in Vietnam

The COVID-19 vaccination in Vietnam is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in response to the ongoing pandemic in the country. Following the approval of the Oxford–AstraZeneca COVID-19 vaccine on 30 January 2021, vaccinations commenced on 8 March 2021, and will continue throughout the year with the goal of vaccinating 80% of the population by June 2022. The Sputnik V was later approved for use on 23 March 2021. Sinopharm COVID-19 vaccine was approved for emergency use on 4 June 2021, while Pfizer–BioNTech COVID-19 vaccine, Moderna COVID-19 vaccine and Janssen COVID-19 vaccine were approved on 12 June 2021, 29 June 2021, and 15 July 2021, respectively. Vietnam approved Abdala vaccine from Center for Genetic Engineering and Biotechnology on 18 September 2021, and Covaxin from Bharat Biotech on 10 November 2021.

COVID-19 vaccination in Mexico Plan to immunize against COVID-19

COVID-19 vaccination in Mexico is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in Bangladesh

Bangladesh began the administration of COVID-19 vaccines on 27 January 2021 while mass vaccination started on 7 February 2021.

COVID-19 vaccination in Taiwan Plan to immunize against COVID-19

COVID-19 vaccination in Taiwan is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in response to the ongoing pandemic in the country. Following the approval of the Oxford–AstraZeneca COVID-19 vaccine on 18 March 2021, vaccinations commenced on 22 March 2021, and will continue throughout the year with the goal of vaccinating 70% of the population by late October 2021.

COVID-19 vaccination in Ukraine Plan to immunize against COVID-19

The COVID-19 vaccination campaign in Ukraine is an ongoing mass immunization campaign for the COVID-19 pandemic in Ukraine.

References

  1. Germany COVID-19 Vaccine Tracker: States Map. By George Karabassis. Click on the 1M button on the bottom right of the map and on the 2x button to produce the map shown.
  2. "Erste Corona-Impfungen in Halberstadt: Pieks für 101-Jährige" (in German). dpa. 26 December 2020. Retrieved 11 May 2021.
  3. "Aktueller Impfstatus". impfdashboard.de (in German). Federal Ministry of Health (Germany) . Retrieved 2021-09-20.
  4. "COVID-19 vaccines: under evaluation". European Medicines Agency. n.d. Retrieved 15 May 2021.
  5. "Germany restricts use of AstraZeneca vaccine to over 60s in most cases". Deutsche Welle. 30 March 2021. Retrieved 11 May 2021.
  6. "Coronavirus: Germany opens up AstraZeneca COVID vaccines for all adults". Deutsche Welle. 6 May 2021. Retrieved 11 May 2021.
  7. "Johnson & Johnson prioritization lifted" (in German). tagesschau. Retrieved 2 June 2021.
  8. "Vaccination priority" (PDF). German Ministry of Health. Retrieved 10 May 2021.
  9. "Merkel: Germany to let everyone apply for vaccine by June". Deutsche Welle. 26 April 2021. Retrieved 12 May 2021.
  10. "Germany to open up vaccines to all adults from June 7th: What you need to know". thelocal.de. 18 May 2021. Retrieved 2 June 2021.
  11. "Coronavirus in Bavaria: Assistance in English". Bayerischer Rundfunk. Retrieved 12 May 2021.
  12. "Corona-Impfungen in Arztpraxen künftig freigegeben - große Nachfrage". Südwestrundfunk. 12 May 2021. Retrieved 12 May 2021.
  13. "Ab Montag Berlin hebt Impfpriorisierung bei Ärzten auf" (in German). Rundfunk Berlin-Brandenburg. 13 May 2021. Retrieved 13 May 2021.
  14. Thurau, Jens (27 May 2021). "COVID: Germany's Merkel wants vaccines for children aged 12 to 15". Deutsche Welle. Retrieved 2 June 2021.
  15. Doll, Nikolaus (8 August 2021). "Bundesländer geben mehr als zwei Millionen Impfdosen zurück". Die Welt (in German). Retrieved 12 August 2021.
  16. "German Chancellor Angela Merkel kicks off COVID vaccination action week". Deutsche Welle. 12 September 2021. Retrieved 16 September 2021.
  17. "RKI - Coronavirus SARS-CoV-2 - Digitales Impfquotenmonitoring zur COVID-19-Impfung".
  18. "Germany: Merkel, state leaders agree on strategy to jump-start vaccinations". Deutsche Welle. 19 March 2021. Retrieved 16 April 2021.
  19. "Covid: Germany fears thousands got saline, not vaccine from nurse". BBC News. 12 August 2021.